# Fludeoxyglucose F 18

NDC: 76318-334
Generic name: Fludeoxyglucose F-18
Labeler / Manufacturer: Massachusetts General Hospital
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20111030

FDA application: ANDA204333

## Active ingredients

- FLUDEOXYGLUCOSE F-18: 300 mCi/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76318-334"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76318-334
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=232fbb91-402e-44d8-a0cf-6813980b8ead